- Home
- OPP vs ENLV Comparison
OPP vs ENLV Comparison
Compare OPP & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
HOLD
Current Price
$0.72
Company Overview
Basic Information| Metric | OPP | ENLV |
|---|---|---|
| Founded | 2010 | 2005 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 187.4M | 196.2M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | OPP | ENLV |
|---|---|---|
| Price | $7.55 | $0.72 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | 95.5K | ★ 418.0K |
| Earning Date | 01-01-0001 | 05-29-2026 |
| Dividend Yield | ★ 14.41% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.49 | $0.66 |
| 52 Week High | $8.77 | $2.10 |
Technical Indicators
Market Signals| Indicator | OPP | ENLV |
|---|---|---|
| Relative Strength Index (RSI) | 35.04 | 39.84 |
| Support Level | $7.52 | $0.66 |
| Resistance Level | $8.03 | $1.23 |
| Average True Range (ATR) | 0.08 | 0.06 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 27.98 | 20.89 |
Price Performance
Historical Comparison OPP
ENLV
About OPP RiverNorth/DoubleLine Strategic Opportunity Fund Inc.
RiverNorth/DoubleLine Strategic Opportunity Fund Inc is a closed-end management investment company. The company's investment objective is to seek current income and overall total return.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.